Search - tctmd.com

Displaying 21 - 40 of 41

Sort: Relevancy | Date

Presentation TCT 2016

Vietnam Comments: How Would I Treat This Case?

Presenter: Thomas Engstroem, Hyo-Soo Kim, Samer Mansour, Quang Ngoc Nguyen, Hung Manh Pham

October 30, 2016

Presentation TCT 2016

Canada Presents: A Case of "Ad Hoc" Left Main PCI

Presenter: Thomas Engstroem, Hyo-Soo Kim, Samer Mansour, Quang Ngoc Nguyen, Erick Schampaert

October 30, 2016

Presentation TCT 2016

Denmark Presents: How Did I Treat This Case?

Presenter: Thomas Engstroem, Hyo-Soo Kim, Samer Mansour, Quang Ngoc Nguyen, Jens Flensted Lassen

October 30, 2016

Presentation TCT 2016

Canada Comments: How Would I Treat This Case?

Presenter: Thomas Engstroem, Hyo-Soo Kim, Samer Mansour, Quang Ngoc Nguyen, Payam Dehghani

October 30, 2016

Presentation TCT 2016

Denmark Presents: A Case of Restenosis in the Left Main Bifurcation

Presenter: Thomas Engstroem, Hyo-Soo Kim, Samer Mansour, Quang Ngoc Nguyen, Jens Flensted Lassen

October 30, 2016

Presentation TCT 2016

Canada Presents: CABG vs PCI in Left Main Disease

Presenter: Thomas Engstroem, Hyo-Soo Kim, Samer Mansour, Quang Ngoc Nguyen

October 30, 2016

News Daily News

采用第二代 DES 的双支架策略在治疗分叉病变时无劣势

Yael L. Maxwell

August 26, 2015

News Daily News

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Yael L. Maxwell

August 26, 2015

News Daily News

La Estrategia de Doble Stent en Lesiones en Bifurcación con SLF de 2ª Generación No tiene Ninguna Desventaja

Yael L. Maxwell

August 26, 2015

Presentation TCT 2014

TCT 149: Intracoronary Injection of Bone Marrow-Derived Mononuclear Cells, Early or Late After Acute Myocardial Infarction: Long-term Effects on Global Left Ventricular Function Twelve-Month MRI and Long-term Clinical Results of the SWISS-AMI Trial

Presenter: Jonathan M. Hill, Hyo-Soo Kim, Emerson C. Perin, Daniel Suerder, MD

September 15, 2014

Presentation TCT 2014

Enhanced Effects of Primed Peripheral Monocytes

Presenter: Henricus J. Duckers, Stephen E. Epstein, Marc S. Penn, Hyo-Soo Kim

September 15, 2014

Presentation TCT 2014

Follow the Data: Fluorinated Polymer-Based DES are Safer than Bioresorbable-Based DES!

Presenter: Hyo-Soo Kim

September 14, 2014

Presentation Cell Therapy 2014

Cytokine-based peripheral blood stem cell therapy: MAGIC Cell-5-combicytokine trial

Presenter: Hyo-Soo Kim

January 22, 2014

Presentation Cell Therapy 2014

Induction of Endothelial Cell from Fibroblast by 5 Defined Factors

Presenter: Hyo-Soo Kim

January 21, 2014

Presentation Cell Therapy 2013

Scaled-up Method for Cardiosphere Derivation

Presenter: Hyo-Soo Kim

January 23, 2013

Presentation TCT 2012

Stents and Vascular Healing: New Concepts

Presenter: Hyo-Soo Kim

October 22, 2012

Presentation ACC 2012

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Presenter: Hyo-Soo Kim

March 24, 2012

News Daily News

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

March 15, 2012

News Daily News

Celecoxib Enhances DES Efficacy, But at Clinical Cost

March 15, 2012

Presentation Cell Therapy 2012

New, Potent, and Safe Source of Human MSCs: From Human Embryonic Stem Cells

Presenter: Hyo-Soo Kim

January 24, 2012

Advertisement

Vietnam Comments: How Would I Treat This Case?

Canada Presents: A Case of "Ad Hoc" Left Main PCI

Denmark Presents: How Did I Treat This Case?

Canada Comments: How Would I Treat This Case?

Denmark Presents: A Case of Restenosis in the Left Main Bifurcation

Canada Presents: CABG vs PCI in Left Main Disease

采用第二代 DES 的双支架策略在治疗分叉病变时无劣势

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

La Estrategia de Doble Stent en Lesiones en Bifurcación con SLF de 2ª Generación No tiene Ninguna Desventaja

TCT 149: Intracoronary Injection of Bone Marrow-Derived Mononuclear Cells, Early or Late After Acute Myocardial Infarction: Long-term Effects on Global Left Ventricular Function Twelve-Month MRI and Long-term Clinical Results of the SWISS-AMI Trial

Enhanced Effects of Primed Peripheral Monocytes

Follow the Data: Fluorinated Polymer-Based DES are Safer than Bioresorbable-Based DES!

Cytokine-based peripheral blood stem cell therapy: MAGIC Cell-5-combicytokine trial

Induction of Endothelial Cell from Fibroblast by 5 Defined Factors

Scaled-up Method for Cardiosphere Derivation

Stents and Vascular Healing: New Concepts

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

Celecoxib Enhances DES Efficacy, But at Clinical Cost

New, Potent, and Safe Source of Human MSCs: From Human Embryonic Stem Cells

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content